Share Purchase Agreement Clauses for Early Startup Rounds

Share Purchase Agreement clauses shape more than the transaction on the signature page. They determine who owns the company, what a founder can be held liable for, and how much freedom remains in the next funding round. Understanding them before signing is a core founder skill.

Why a Share Purchase Agreement is not always what founders think it is

Three agreements often get mistaken for one another. A Share Purchase Agreement, or SPA, transfers existing shares between shareholders, with the money going to the seller. A Share Subscription Agreement, or SSA, covers new shares issued by the company, bringing capital into the business. A Shareholders’ Agreement, or SHA, governs the relationship afterward, including voting, board composition, and exit rights. In structured deals, the parties often sign all three together, which helps explain the alphabet soup.

The distinction is where the money goes and what obligations remain. Most seed equity issuances use the subscription model, while secondary sales, acquisitions, and founder buyouts are purchases of existing shares. Earlier fundraising often uses SAFEs before a full priced round. Purchase documents become relevant when those SAFEs convert in a priced financing or an existing holder sells, so founders need to understand the clauses across the transaction documents.

How the Restricted Stock Purchase Agreement sets the equity foundation at formation

Before investors arrive, each founder signs a Restricted Stock Purchase Agreement, or RSPA, to buy shares from the newly formed company. It specifies the number and class of shares, usually common stock, and the purchase price, typically $0.00001 per share at formation. The price may be tiny, but the founder still has to pay it. A bank transfer or check and its record prevent unpaid founder stock from becoming a due diligence problem.

The RSPA also establishes vesting and the company’s repurchase right. Standard vesting runs four years with a one-year cliff, with one quarter vesting on the first anniversary and the rest monthly over three years. The start date can go back to when the founder began full-time work, even before incorporation. If a founder leaves early, the company can repurchase unvested shares at the original price, usually within a 90-day window.

Double-trigger acceleration can vest shares after both a sale and termination or a materially reduced role, while sale-only acceleration is harder to obtain. The agreement also covers transfer restrictions, IP assignment, and founder representations about the purchase. Spousal consent may subject a spouse’s ownership interest to the same restrictions. Missing assignments and wrong vesting dates tend to come to light when an investor is already waiting.

The 83(b) election: the tax filing attached to the RSPA that founders must not miss

An 83(b) election lets the founder choose taxation at the grant date, when the shares may be worth nearly nothing. The deadline is 30 days from share issuance. Missing it cannot be remedied afterward, even if nobody mentioned the filing when the RSPA was signed.

Without the election, vesting can generate ordinary income tax based on the shares’ fair market value, potentially creating a substantial bill on equity the founder cannot sell. The election must be filed with the IRS, with a copy sent to the company. Some states impose additional filing requirements. A signed stock agreement is not a completed tax filing.

What representations and warranties actually obligate a founder to disclose

Representations and warranties are statements that the parties are legally bound by. They typically cover financial statements, legal compliance, IP ownership, litigation, taxes, and the absence of a material adverse change since the last financial statements. A false statement can support a damages claim after closing. Calling it a “standard rep” does not remove a founder’s individual exposure as a seller.

Before signing, founders need to check that each statement is true. A prior employer’s IP claim or unresolved tax issue may contradict language that initially looks harmless. The disclosure schedule is the seller’s primary defensive tool because it records known exceptions to the representations. Those exceptions need the same attention as the promises themselves.

The promises also run in both directions. Investors make representations about authority and applicable securities compliance. The NVCA’s October 2025 model-document update added two-way representations reflecting heightened U.S. national security and data security oversight. An industry-benchmark draft is therefore a starting point for review.

IP assignment inside the SPA and why it must survive a co-founder's departure

Under U.S. copyright law, ownership defaults to the individual creator, so the company may not own its product without an express assignment in the purchase agreement or a separate agreement. The assignment must cover both pre-incorporation work and future work created in the founder’s capacity. Incorporation alone does not move code into the company’s hands.

Equity vesting and IP ownership each need a commitment that stands on its own. Vesting sets which shares a founder keeps when leaving, while a survival clause keeps the IP assignment in force whatever the founder’s employment status, vesting position, or relationship with the company. Founders should verify both before signing. Otherwise, a former co-founder may still own core IP, which can block institutional funding until the ownership issue is fixed. That is a poor time to discover who has negotiating leverage.

Transfer restrictions — ROFR, drag-along, and tag-along — and what they mean for cap table control

A right of first refusal, or ROFR, lets the company buy shares on the terms offered by an outside buyer before the transfer proceeds. Before a priced round, the company is typically the sole holder of that right. Investors then obtain their own ROFR through a separate agreement, giving existing stakeholders a chance to prevent unwanted shareholders from entering.

Drag-along and tag-along rights govern what happens at sale. Drag-along lets a defined majority or coalition compel minority holders to join a company sale on the same terms. Founders should negotiate the triggering threshold and whether separate founder consent is required, because the right can eventually operate against them. Tag-along lets other holders, typically investors, sell a proportional stake when a founder or major holder sells.

The triggers are as important as the labels. These clauses protect investors from acquisitions being blocked or from being stuck with shareholders they do not know. Unauthorized transfers and missing ROFR waivers can also delay or kill a Series A round during cap table review.

Conditions precedent and indemnities: the closing mechanics that can stall or undo a deal

Conditions precedent set out what must happen before the deal can close and the investor has to provide the money. Common requirements include board resolutions, regulatory approvals, third-party consents, an updated cap table, signed founder agreements, and clean due diligence. Each condition can become a delay, especially when someone outside the deal must act.

For founders negotiating as sellers, the practical goal is a short conditions list that could permit funding on signing day. After closing, indemnities define compensation owed if a representation or warranty proves incorrect. The cap limits total exposure, while the basket establishes the losses the buyer must absorb before the obligation triggers. The survival period governs the post-closing window. Founders should negotiate all three, since these legal terms can be changed.

Anti-dilution provisions and protective provisions: how investor rights clauses constrain future fundraising

Broad-based weighted-average protection adjusts an investor’s conversion price using both the number and price of newly issued shares. Full-ratchet protection instead adjusts to the full down-round price regardless of deal size, making it less founder-friendly. Seed terms also commonly include a 1× non-participating liquidation preference, giving investors priority repayment without an additional share of the remaining proceeds. Participating preferred allows both, so founders should flag it.

Protective provisions constrain decisions through standard consent rights covering new shares, significant debt, a company sale, charter amendments, and board-size changes. Founders should push back on vetoes over routine hiring, compensation, or product direction. Otherwise, ordinary management can become a permission queue.

The NVCA update also formalized optional language for milestone-based, or tranched, financings. Under that language, an investor who fails to fund a committed tranche can have previously purchased preferred stock converted into common stock. That removes liquidation preference, anti-dilution protection, and other protective rights from those shares. The provision holds investors to their funding commitments, but founders still risk being unable to carry out their plans if the milestones are open to interpretation. Each milestone should be objectively defined and measurable before signing.

Board composition clauses and the governance rights that shift with each round

Investor rights set the rules, while board composition decides who makes decisions within them. The seed-stage standard is two founder seats and one investor seat, preserving founder control. At Series A, the standard shifts to two founders, two investors, and one mutually agreed independent director. Neither side then has unilateral control. The independent director becomes the swing vote on contested decisions.

That shift can reach the founder’s own job. Standard governance permits CEO removal by simple board majority, so the two investor directors and the independent can together remove a founder-CEO. Founders should negotiate a separate, named protection requiring a supermajority or an additional founder vote for that decision. Board terms also need to be read with shareholder consent rights, since board control does not override those rights. Understanding the seed baseline makes the Series A negotiation more predictable.

Where the SAFE fits in the SPA sequence and what founders owe investors when it converts

For many founders, investor financing starts with a SAFE. Its valuation cap sets the maximum valuation used for conversion, potentially giving the holder a better price than new priced-round investors. A discount instead reduces the next round’s price by an agreed percentage. An MFN provision allows the holder to adopt more favorable terms from a subsequent SAFE. These commitments precede the priced-round negotiation.

The standard post-money form makes ownership sold calculable at signing by dividing the investment by the post-money valuation cap. This helps founders see how much dilution to expect before conversion, though they can still lose more equity than expected if they have multiple SAFEs with different caps. YC uses a fixed-percentage post-money SAFE plus an uncapped MFN SAFE that converts on the most favorable applicable terms issued between its specified start date and the priced round. At conversion, those earlier commitments meet the priced-round documents, where representations, transfer restrictions, investor protections, and board rights are negotiated.

Federal and state securities compliance requirements founders must satisfy when issuing equity

Even founder stock is a securities offering under U.S. federal law. Investor rounds typically rely on Regulation D, Rule 506(b), which permits sales to accredited investors and up to 35 sophisticated non-accredited investors without SEC registration. Founders should keep a record of which exemption applies to each issuance. A private agreement between co-founders does not remove this layer.

State rules create a separate compliance obligation. Delaware does not require a state notice filing for federal private-placement offerings, but a company incorporated there still has to meet the rules that apply in other states. California requires notice filings for certain issuances, and failures can create rescission rights or penalties. When founders or investors span states, each relevant state’s requirements need review.

Missing exemptions, notices, or approvals can require remediation while a round is underway. Board resolutions and consents should therefore be kept on file for good so that no one has to hunt for them before closing.

A practical pre-signing checklist for early-stage founders reviewing any SPA

A founder’s first-pass review should start with formation records. Confirm payment for shares, the vesting start date, and IP assignment covering work before and after incorporation with an independent survival clause. Track the 83(b) filing against the issuance date and retain the securities-exemption documentation.

For investor documents, read every representation against the disclosure schedule. Identify the indemnity cap, basket, and survival period, then challenge closing conditions that depend on third parties. Map transfer-right triggers and consent thresholds, and flag full-ratchet protection, participating preferred, or operational vetoes. Compare board composition with the round’s baseline and require measurable milestones in any tranched financing. The valuation is only one term on the page.

This review prepares founders to work with experienced startup counsel. Startup School, Y Combinator’s free online course, is one educational option covering founder equity, SAFEs, cap table mechanics, and fundraising instruments. Understanding the terminology and sequence helps founders bring better questions to the professional who reviews the deal.